Table of Contents Table of Contents
Previous Page  103 148 Next Page
Information
Show Menu
Previous Page 103 148 Next Page
Page Background

Table 7

Oncological outcomes of included patients with a history of urothelial carcinoma: renal transplantation (I) versus renal replacement therapy (C)

Study (1st author, yr)

Primary

management

Arms (no. of patients)

Oncological outcomes

Histological outcomes

Follow-up

a

(yr)

Recommendations concerning waiting

period & prognostic factors of

recurrence, according to authors of the

included studies

Cancer

recurrence

Cancer

speci

fi

c

survival

Overall

survival

Location

Stage

Grade

5 yr

>

5 yr

Chapman, 2001

[46]

NS

I (24)

NS

4.2% NS

NS

NS

NS

NS

NS

-Prognostic factor of recurrence:

- Diagnosis of cancer while on

dialysis vs before dialysis

- Waiting period:

-

>

2 yr

-

>

5 yr if cancer diagnosed while on

dialysis

C (93)

NS

24% NS

NS

Penn, 1997

[4]

NS

I (55)

NS

29% NS

NS

NS

NS

NS

>

5

- Bladder cancer = high risk of

recurrence

- Waiting period:

- 2 yr for low-grade bladder cancer

-

>

5 yr for high-grade bladder cancer

Joshi, 2008

[29]

1 TURB

I (1)

0% 0% 100% (

>

5 yr) 100% (

>

5 yr) Bladder 100% T1 100%

G2 100% 9

Chang, 2007

[42

]

8 NUT

4 NUT + TURB

I (12)

NS

NS

96% (1

5 yr) 79% (1

5 yr) Bladder 65%

Ureter 42%

Renal pelvis 15%

Multifocal 27%

Ta 12%

T1 69%

T2 15%

T4bN1M1 4%

G1 12%

G2 73%

G3 15%

1.6

- High rate of contralateral tumour

- Do not recommend systematic

contralateral NUT but close

monitoring before transplantation

Hung, 2009

[43]

46 NUT

C (46)

NS

32% 98% (

>

5 yr) 88% (

>

5 yr) Bladder 29%

UUT 71%

Multifocal 54%

T1

2 71%

T3

4 29%

G1 9%

G2

3 91%

12.6

Kang, 2010

[21]

13 NUT

64 NUT + cystectomy

C (67)

NS

53% 96% (

>

5 yr) 43% (

>

5 yr) UUT 100%

Ta/T1 56%

T2 14%

T3

4 30%

G1 17%

G2 30%

G3 53%

5 (5.6

10.2) - Synchronous contralateral tumour

10%

- Asynchronous bladder tumour 39%

- Do not recommend systematic

bilateral NUT before transplantation

but close monitoring

Li, 2016

[44]

72 TURB + intravesical

chemotherapy

(BCG excluded)

C (72)

40% 57% NS

60% (

>

5 yr) Bladder 100% Ta 66%

T1 34%

G1

2 31%

G3

4 69%

5.2 (4

7)

Ou, 2000

[45]

2 NUT

1 NUT + TURB

11 TURB

C (17)

50% NS

92% (1

5 yr) 75% (1

5 yr) Bladder + UUT Stage 0/A 82%

Stage B1 6%

Unknown Stage 12%

NS

NS

Wu, 2006

[20]

28 NUT unilateral

4 NUT bilateral

23 Urinary tract

exenteration

C (55)

55% NS

86% (

>

5 yr) 86% (1

5 yr) Bladder + UUT Ta 46%

T1 19%

T2 12%

T3 22%

T4 1%

G1 5%

G2 70%

G3 25%

2.5

- Bilateral involvement 16%

- Contralateral recurrence 31%

- Propose: bilateral NUT for young

patients and waiting period 2 yr

before transplantation

C = control; I = intervention; NS = not stated; NUT = nephroureterectomy; TURB = transurethral bladder resection; UC = urothelial cancer; UUT = upper urinary tract

.

a

From cancer treatment to last news.

E U R O P E A N U R O L O GY 7 3 ( 2 0 18 ) 9 4

10 8

103